Connect with us

Cannabis

A Cronos Group Spent $110 Million To Buy Marijuana MSO PharmaCann Stake

Published

on

A Cronos Group Spent $110 Million To Buy Marijuana MSO PharmaCann Stake

The signing of marijuana business deals between various national and international companies has increased. Cronos Group and MSO PharmaCann are also working towards signing some business deals to expand their companies.

Canopy Growth and Acreage Holdings are also signing some business agreements. Multiple other multinational companies are also considering various deals. Marijuana deals enable companies to expand their business and reach new markets. There are benefits of such agreements for both parties. Companies for their mutual advantages agree to co-operate with one another.

Cronos Group is a Toronto-based cannabis company that produces and distributes cannabinoids across the globe. The international marijuana company has signed multiple business agreements and continues to do so, to enhance its access to the market. Recently, Cronos Inks brought a stake at around 110.4 million from the MSO PharmaCann.

ALSO READ: Convincing Minorities To Begin Medical Cannabis Involving Activities

PharmaCann is one of the biggest marijuana companies doing business in six states of the United States. The company through much efforts has built an effective and legally operate-able model to increase its approach to the cannabis market. It has six production facilities and is selling its product via 23 dispensaries under the brand name VerilifeTM. However, the sale of products of PharmaCann only occurs in six states. These states include New York, Illinois, Ohio, Maryland, Pennsylvania, Massachusetts.

 

Buying Of Marijuana MSO PharmaCann Stake 

The Cronos Group spent 134 Canadian dollars to purchase an Option of MSO PharmaCann through a third party. The aim of purchasing PharmaCann’s stake is to enhance the medical marijuana business. Moreover, after purchasing the stake, Cronos Inks stock rise above 2.6%.

The extent to which Cronos Group uses the Option depends upon multiple factors. Two of these factors include federal marijuana policy regarding legalization and regulatory approvals, including the states where PharmaCann operates cannabis business activities.

Kurt Schmidt is the President and Chief Executive Officer of Cronos Group. According to Kurt Schmidt, the U.S. strategy of Cronos focuses on delivering long-term shareholder value.

Kurt Schmidt elaborates that the decision of investing in PharmaCann was taken because of their disciplined capital allocation. Good track-record keeping, compelling licensed manufacturing, and reliable retail setup of MSO PharmaCann attracted Cronos Group, and they decided to invest.

PharmaCann and Cronos Group joined hands as both have committed themselves to improve product quality and consistency. They are willing to modify manufacturing and operating strategies to increase marijuana product quality by using science and the latest technology.

 Transaction Terms And People Involved In Decision Making

According to Brett Novey, Crnos’s investment in PharmaCann highlights the ability to enhance and flourishing business. Moreover, Novey said that they are excited to work with Cronos Group to improve lives of patients through marijuana.

Cronos Group and PharmaCann will enter into a commercial agreement allowing both companies to sell their products utilizing the distribution channels of either of the two companies.

ALSO READ: Free Cannabis For Getting Your COVID-19 Vaccination

Transaction terms are approved by multiple authorities collectively, including the PharmaCann Board of Directors, PharmaCann shareholders, Cronos Group Board of Directors, and a special committee of independent directors.

Cowen was the financial advisor to the committee of independent directors of marijuana Cronos Group. Sullivan and Cromwell LLP and McGuireWoods LLP served as legal advisors to the committee. The financial advisor to Altaria Group Inc. was Perella Weinberg Partners LP. Legal advisor to PharmaCann in this transaction are from Fox Rothschild LLP. Canaccord Genuity Corp also served as financial advisor to PharmaCann.

Michael S. Lavery is an analyst at Piper Sandler. According to Micheal S. Lavery, federal legalization of marijuana can open gates for more foreign investors. However, it can take several years to generate revenue from such business deals.

The author is a graduate of dental surgery from the Dow University Health Sciences, Karachi. She has an academic background in content writing as well as English literature, giving her an edge in the field. Adeena is always curious about physical and mental health. She is always passionate about research and delivering high-quality reliable content to users.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

Recycling Of Tonnes Of Cannabis Containers

Published

on

Cannabis Recycling

Cannabis products formulations in solid, liquid, and smoke-able forms are available in the market for medical and recreational use. Marijuana products are kept under storage conditions set out by the manufacturer. 

 

Cannabis products come in containers of variable sizes and shapes. The material used to prepare containers depends upon the manufacturer’s choice and demand for the stability of marijuana products. 

ALSO READ: Cannabis Products Association With Perceived Risks And Availability

 

Recycling of containers is occurring for decades to reuse items or process used items into new ones. Doing so reduces pollution and helps to use one material multiple times. 

 

Returning And Recycling Of Cannabis Containers To SDQC

 

In less than 12 months, about 21 tonnes of empty plastic containers were sent to recycle to the SQDC. SQDC is the company that does the recycling under the name Societe Quebecoise du cannabis. It is a government-owned company. 

 

The company began its recycling package or recovery program in August 2020. Since August, a lot of plastic containers have gone through recovery programs, precisely 2291143 containers.

 

The use of cannabis products has hugely increased in the market. The number of marijuana containers purchased by consumers is likely to be much more than the number of containers send to SQDC to recycle. There is only a deposit on SQDC beverages included in the RECYCQUEBEC consignment system. 

 

However, there is no deposit on the SQDC containers in the system. Quebecers who do return pot containers do so not for money as they do not get money. They do so to keep containers away from trash.

 

According to the SDQC, the benefit of returning empty containers is that others materials cannot contaminate cannabis containers. Moreover, doing so ensures that these packaging materials do not end up in the blue boxes. Collecting these empty plastic packaging allows sending a uniform material to businesses that reuse it easily after quick processing.

 

What Happens To Marijuana Containers After Recycling

 

The Societe Quebecoise du cannabis signed a partnership with TerraCycle. TerraCycle is a U.S.-based recycling business company. The SQDC sends collected cannabis containers to TerraCycle and other such companies that are in agreement to recycle them. 

 

TerraCycle recycling business company focuses on using the used items to form urban furniture such as park benches, flower boxes, etc. According to some individuals, TerraCycle recycles bags that could have added to pollution or result in a landfill otherwise.

 

According to the Canadian press, it is uncertain what happens to those containers. It is also unclear how many of such packagings go into and out of the company. No one knows the exact number of plastic packaging required to produce urban furniture. Furthermore, there is little knowledge about other formulations that use this recyclable material. So far, there is no way to find it as the TerraCycle recycling business company does not respond to emails or phone calls as per the Canadian press. 

ALSO READ: Changes In Cannabis Proposed Ordinance By Santa Fe County Planning Commission

 

The SQDC, in a Facebook post on a page, announces that they will continue to work to improve the environment. They are working with a team of experts to develop an efficient action plan for cannabis containers and packaging recycling that is eco-friendlier. They are looking forward to going further with their environmental efforts. 

Environmentally Unsustainable?

Some people are criticizing SDQC for its products that are considered over-packaged or are environmentally unsustainable. Individuals complain that they have to wait in line to return the cannabis containers, and it would be much better if SQDC places outdoor bins in front of SQDC branches. Some individuals, while returning multiple marijuana containers, feel embarrassed. 

 

SQDC replied to these complaints and said that they are aware of the critical remarks. However, they cannot do much about it as they are to abide by the law. Placing outdoor bins cannot ensure control over the material. Outdoor recycling bins can increase the risk of accidental cannabis consumption in children and youth.  

Continue Reading

Cannabis

Pot Legal In NYC But Where To Buy Recreational Cannabis In New York

Published

on

Cannabis Companies Making Moves Before New York Begins Recreational Cannabis Sales

Pot products, including recreational cannabis and medical marijuana products, are legal in New York. The lawmakers have successfully approved the weed legalization and decriminalization bill. However, the administration working and policies to implement the bill is taking way too much time. 

 

The disagreements among legislators and the inability to develop a plan to implement the legislation delays implementation of the new bill. Due to delays in proceeding procedures, things have become difficult for almost everyone. 

 

Cannabis Legalization Program Of New York – A Train To Nowhere

 

Governor Andrew Cuomo and state legislatures did approve cannabis legalization and decriminalization bill in March this year. However, there has not been much progress. According to critics, the Governor is the real buzzkill on the issue. 

ALSO READ: Cannabis Products Association With Perceived Risks And Availability

Critics elaborate that Cuomo is yet to nominate an executive director for his new Office of Cannabis Management. He also has to name appointees to the Cannabis Control Board. The Marijuana Taxation and Regulation Act were passed months ago, yet the official is working slowly to appoint and name some people for the office to begin further proceedings. 

 

The Governor is delaying the procedure because the Senate members have not yet passed Cuomo’s proposed MTA legislation. Richard Azzopardi is the spokesperson of Gov. Andrew Cuomo. According to his spokesperson, there are multiple unfinished businesses in Senate. However, they will submit their nominees and names for designated positions. The spokesperson also mentioned that they hope Senate passes MTA legislation and let nominees selected by the governor implement order regarding cannabis. 

 

Politicians Against Delay In Implementation Of Cannabis Legalization Policy In New York 

 

Mike Murphy is the spokesman for Senate Leader Andrea Stewart Cousins. According to Murphy, MTA approval and nominating nominees are separate issues with no interlinkage. Thus, these matters need separate resolutions, and it is best not to try to relate them. 

 

According to State Senator Diane Savino, after observing the current situation, it is evident that the cannabis legalistic program is likely to delay for much a longer time. She added that the public and officials of New York are in between a rock and a solid hard place. 

 

Moreover, apart from the politicians, the public is angry and frustrated at the delay of matters. Residents of the state are unable to understand the logic or reasoning behind the pending situation. 

 

According to Diane Savino, legislatures or lawmakers should walk and sign a joint agreement at the time regarding the subject to settle things as quickly as possible.

 

The politician further added that nothing can happen concerning marijuana sale policy and license issuance to begin a legal business. At least until regulators develop a set of ground rules to conduct cannabis business, following legal practices is impossible. 

 

What Is More About Marijuana Policy In New York State?

 

According to Diane Savino, no operation involving marijuana is practicable unless legislators set some ground rules. Licenses to individuals to begin a legal sale, cultivation, processing, manufacturing, or distribution of marijuana is unapprovable before settling some limitations. Moreover, it is inappropriate to approve licenses without designing a regulatory system. 

ALSO READ: Cannabis Dealer Stopped By Police

Governor needs to select three people to begin the formation of the five-member Cannabis Control Board. The nominees will first get approval from the Senate to offer their services. The selection of the other two members falls on the legislatures. One member of the five-member committee will be selected by lawmakers from the Assembly and one from the Senate. 

 

The selection of nominees and their approval is the next step after passing the bill, and it took almost a year for completion. Delaying the process cause trouble for the state and the public who had to go to borders to purchase cannabis legally from neighboring states like Massachusetts. 

 

Unless the regulatory and administrative procedures are incomplete, the state is unable to generate revenue. Pending them will only slow down the development process of the cannabis business field and delay experiencing possible benefits from its tax revenue. 

Originally covered on: NYPost

Continue Reading

Cannabis

Cannabis Products Association With Perceived Risks And Availability

Published

on

Medical cannabis

Cannabis products are in use for medical and recreational purposes in more than thirty states of the United States. Some of these states allow medical marijuana products, while others allow pot for all purposes, including adult and medical purposes. 

 

Multiple studies have been conducted relating to cannabis, including pot effects and associations with other factors. Perceived risks and availability links with marijuana use disorders. Moreover, research findings can demonstrate how perceived risks can alter pot use disorders in individuals. 

 

According to a new study at Columbia University Mailman School of Public Health, perceptions of the risks and availability of cannabis influence the risk of pot use. This influence is more than the perceived risk and effect of perceived availability alone. 

ALSO READ: Marijuana Growing In Zimbabwe Is The New Farming Trend

 

The research discovers that individuals that perceive cannabis as a low-risk and available drug are more likely to use cannabis. There are some other findings too. Researchers discovered that individuals with perceptions that cannabis is high-risk and unavailable drug report fewer drug use cases. You can find research discoveries in the journal Drug and Alcohol Dependence. 

 

More About Research Regarding Perceived Risks And Availability Effects On Cannabis Use

 

Natalie Levy is a Doctoral Student of the Department of Epidemiology at Columbia Mailman School and the first author of the study. According to this research, perception of cannabis risk affects its use, frequency of use, and pot use disorders. Moreover, the availability of cannabis does influence the chances of drug use, its frequency, and marijuana use disorders. 

 

However, the findings show that cannabis risks and availability together influence pot use more frequently. The research focused on the evolution of collective perceptions of marijuana risk and availability from 2002 to 2018. 

 

Data of 949,285 participants helped in doing the investigation or survey studies. These participants are from the National Surveys on Drug Use and Health. Researchers found that over the years from 2002 to 2018, more people perceive marijuana as a low-risk drug. The prevalence of individuals who perceive pot as a low-risk drug doubled in these years. However, the influence of the change in availability perception was comparatively less evident. 

 

The joined perceptions influence was evident in these years. The percentage of individuals with the perception of cannabis as low-risk and available increased from 17% to 36% from 2002 to 2018, respectively. The number of individuals who perceive marijuana as a high-risk and available or unavailable drug decreases in these years. The percentage of people who perceive pot as high-risk and available is 26 percent. Meanwhile, the percentage of individuals that consider weed as high-risk and unavailable is twenty-seven percent. 

 

Marijuana Perception Effects

 

According to findings, individuals who regard cannabis as low-risk have reported and are likely to report six times more about pot use. Individuals with the perception of cannabis being available are five times more likely to use pot.

ALSO READ: Cannabis Legislation Back From The Dead For Better In Arizona

However, joined perceptions increase the chances of pot use. Individuals with joined perceptions are twenty-two times more likely to use marijuana. That is, people who perceive cannabis as a low-risk and available drug are more than 22 times more likely to use pot than people with the opposite perception.

 

Marijuana perceptions vary from males to females. A large percentage of the male population views marijuana as a low-risk, more available drug when compared to females. Researchers noted variations in pot perceptions in different age groups of each gender. According to the study, individuals of age 12-17 years show minimal cannabis perception differences. 

 

Silvia Martins, MD, Ph.D., is an associate professor of epidemiology at the Columbia Mailman School. She is the director of the Substance Use Epidemiology Unit of the Department of Epidemiology. She is also the senior author of the study. According to Martins, their research will open a new pathway for searching specific hypotheses. Moreover, the study highlights the importance of exploring joint perceived risks and availability on cannabis use. 

Originally covered on: news-medical

Continue Reading

Trending

error: Content is protected !!